Raysa Morales‐Demori

Author

Rush University Medical Center ORCID

Also Known As

R. Morales-Demori, Raysa Morales Demori, Raysa Morales-Demori, Raysa Morales‐Demori

Publications

235

Citations

H-Index

Concepts

All Affiliations

Rush University Medical Center University of Illinois Chicago John H. Stroger, Jr. Hospital of Cook County University of Illinois Hospital & Health Sciences System

About

Raysa Morales‐Demori is an author at Rush University Medical Center specializing in medicine, cardiology, and heart failure.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	112
2	Public Health	3	3	85
3	Pharmacology	2	2	68
4	Health Policy	1	1	17
5	Nephrology	1	1	13

Raysa Morales‐Demori

Publications

112

Citations

H-Index

Page 1

	Year	Citations
Attenuation of the side effect profile of regadenoson: A randomized double-blinded placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging. “The ASSUAGE trial” Rami Doukky, Raysa Morales‐Demori, Sidharth Jain, Journal of Nuclear Cardiology Side Effect ProfileCardiovascular DiseaseMyocardial Perfusion ImagingMyocardial InfarctionPharmacology	2012	58
Epidemiology of Pediatric Heart Failure in the USA–a 15-Year Multi-Institutional Study Raysa Morales‐Demori, Elena Montañés, Gwen Erkonen, Pediatric Cardiology Heart FailureCardiovascular EpidemiologyHealth PolicyPediatric EpidemiologyCardiovascular Disease	2021	17
The impact of regimented aminophylline use on extracardiac radioisotope activity in patients undergoing regadenoson stress SPECT myocardial perfusion imaging: A substudy of the ASSUAGE trial Wassim Ballany, Khaled Mansour, Raysa Morales‐Demori, Journal of Nuclear Cardiology Heart FailureRadiologyAssuage TrialCardiogenic ShockMyocardial Infarction	2014	14
Severe chronic kidney disease as a predictor of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: A substudy of the ASSUAGE and ASSUAGE-CKD trials Maria Octavia Rangel, Raysa Morales‐Demori, Sarah T. Voll, Journal of Nuclear Cardiology Assuage-ckd TrialsHeart FailureRenal FunctionKidney FailureChronic Kidney Disease	2014	13
Age and Gender as Predictors of Benefit From Aminophylline Administration in Patients Undergoing Regadenoson Stress Myocardial Perfusion Imaging Maria Octavia Rangel, Raysa Morales‐Demori, Rami Doukky American Journal of Therapeutics Heart FailureAminophylline AdministrationCardiovascular PharmacologyPharmacotherapyExperimental Pharmacology	2013	10

Page 1